statistiche ricercatore

Nome	#
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori	720
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754)	190
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)	179
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation	174
A practical and expeditious method for the preparation of the anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)	143
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships	131
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors	129
Identification of a Bioactive Impurity Present in a Sample of URB754	118
α-Acylamino-β-lactones as a new class of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors: synthesis and structure–activity relationships	117
Inhibitors of lysosomal lipid amidase NAAA	95
On the formation of CH3-S-S-CH3-+..	85
Totale	2.081

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	86	0	0	0	0	0	0	0	0	0	10	16	60
2019/2020	359	73	9	16	50	8	29	24	35	13	24	20	58
2020/2021	314	25	45	20	30	10	22	21	19	37	25	42	18
2021/2022	181	11	22	13	19	11	8	19	12	9	17	3	37
2022/2023	235	30	23	10	18	23	42	2	27	31	7	12	10
2023/2024	83	14	4	17	9	11	13	11	3	0	1	0	0
Totale													2.081